| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 06/23/2005 | CA2548750A1 Lawsonia intracellularis 26 kd subunit vaccine |
| 06/23/2005 | CA2548749A1 High-level expression of fusion polypeptides in plant seeds utilizing seed-storage proteins as fusion carriers |
| 06/23/2005 | CA2548567A1 Anti-mpl antibody |
| 06/23/2005 | CA2548150A1 Polynucleotides for reducing respiratory syncytial virus gene expression |
| 06/23/2005 | CA2548140A1 Oligosaccharide compositions and use thereof in the treatment of infection |
| 06/23/2005 | CA2548030A1 Wheat having reduced waxy protein due to non-transgenic alterations of a waxy gene |
| 06/23/2005 | CA2548015A1 Human anti-pseudomonas-aeruginosa antibodies derived from transgenic xenomouse |
| 06/23/2005 | CA2547922A1 Viral particles containing an alphavirus-derived vector and method for preparing said viral particle |
| 06/23/2005 | CA2547569A1 Recombinant factor viii having increased specific activity |
| 06/23/2005 | CA2546914A1 Production of amino sugars |
| 06/23/2005 | CA2543257A1 Methods and compositions for delivering polynucleotides |
| 06/23/2005 | CA2494573A1 Novel inducible genes from alfalfa and methods of use thereof |
| 06/22/2005 | EP1544655A2 Patch for microarray reaction chamber having adhesive means support and two or more adhesive materials |
| 06/22/2005 | EP1544309A1 Assay for detecting methylation status by methylation specific primer extension (MSPE) |
| 06/22/2005 | EP1544305A1 Adapter for docking a substance to the cell wall |
| 06/22/2005 | EP1544304A1 Novel serine protease |
| 06/22/2005 | EP1544303A2 Modification of plant metabolism |
| 06/22/2005 | EP1544302A1 KNOCKIN NONHUMAN ANIMAL AND TISSUE-SPECIFIC MnSOD-KNOCKOUT NONHUMAN ANIMAL |
| 06/22/2005 | EP1544301A1 DNA molecules that code for enzymes involved in starch synthesis, vectors, bacteria, transgenic plant cells and plants containing said molecules |
| 06/22/2005 | EP1544300A1 Novel glycosyltransferase genes |
| 06/22/2005 | EP1544299A1 Modified chimeric polypeptides with improved pharmacokinetic properties |
| 06/22/2005 | EP1544298A1 Cultured xenopus laevis cell lines expressing mutant adenomatous polyposis coli gene |
| 06/22/2005 | EP1544297A2 Medicament for treatment of Duchenne muscular dystrophy |
| 06/22/2005 | EP1544296A1 Method for massive directed mutagenesis |
| 06/22/2005 | EP1544293A1 Antibody against enzyme specifically cleaving von villebrand factor and assay system using the same |
| 06/22/2005 | EP1544292A1 Glucose dehydrogenase |
| 06/22/2005 | EP1544210A1 Novel notch-origin polypeptides and biomarkers and reagents using the same |
| 06/22/2005 | EP1543838A1 Feline infectious peritonitis vaccine |
| 06/22/2005 | EP1543837A1 Virus-like particle (VLP) as vaccine |
| 06/22/2005 | EP1543833A1 Phosphorylated dextran |
| 06/22/2005 | EP1543722A1 Nonhuman animal reproducing pathogenic conditions of spinal and bulbar muscular atrophy and remedy for spinal and bulbar muscular atrophy |
| 06/22/2005 | EP1543327A2 Method for assaying compounds or agents for ability to decrease the activity of microsomal prostaglandin e synthase or hematopoietic prostaglandin d synthase |
| 06/22/2005 | EP1543325A2 Flea and tick octopamine receptor nucleic acid molecules, proteins and thereof |
| 06/22/2005 | EP1543324A2 Methods and compositions for grafting functional loops into a protein |
| 06/22/2005 | EP1543163A2 Genetic analysis and authentication |
| 06/22/2005 | EP1543162A1 Compositions of solution for sequencing reaction clean-up |
| 06/22/2005 | EP1543160A1 Uncoupling of dna propagation and expression of protein for phage display |
| 06/22/2005 | EP1543159A2 Antisense modulation of endothelial specific molecule 1 expression |
| 06/22/2005 | EP1543158A1 Regulated aptamer therapeutics |
| 06/22/2005 | EP1543154A2 Abasic site endonuclease assay |
| 06/22/2005 | EP1543149A1 High resolution analysis of genetic variation within cryptosporidium parvum |
| 06/22/2005 | EP1543145A2 Antifungal therapeutic targets |
| 06/22/2005 | EP1543141A2 Quantitative rt-pcr to ac133 to diagnose cancer and monitor angiogenic activity in a cell sample |
| 06/22/2005 | EP1543131A1 Method of producing and screening antibodies produced in transgenic plants |
| 06/22/2005 | EP1543129A2 Virus induced gene silencing in plants |
| 06/22/2005 | EP1543128A2 Viral vectors containing recombination sites |
| 06/22/2005 | EP1543127A2 Nucleic acid sequences coding for proteolytic enzymes in the form of specific proteases, corresponding polypeptides and use of the same |
| 06/22/2005 | EP1543126A2 A GENE ENCODING VITAMIN B sb 6 /sb PHOSPHATE PHOSPHATASE AND USE THEREOF |
| 06/22/2005 | EP1543125A2 Enone reductase gene and microbial production of levodione |
| 06/22/2005 | EP1543124A1 Dna encoding flavin-adenine-dinucleotide-dependent-d-erythronate-4-phosphate-dehydrogenase , pdxr , and microbial production of vitamin b6 |
| 06/22/2005 | EP1543123A2 Acc gene |
| 06/22/2005 | EP1543122A2 Bitter taste receptors |
| 06/22/2005 | EP1543121A1 Method for designing peptides |
| 06/22/2005 | EP1543119A2 Methods of inhibiting hiv-1 vpr activity and hiv-1 infectivity using atr or rad17 inhibitors |
| 06/22/2005 | EP1543115A2 Squalene synthase (sqs) gene |
| 06/22/2005 | EP1543114A2 Aldehyde dehydrogenase gene |
| 06/22/2005 | EP1543110A2 Mesoderm and definitive endoderm cell populations |
| 06/22/2005 | EP1543105A1 New mutant strains of pseudomonas fluorescens and variants thereof, methods for their production, and uses thereof in alginate production |
| 06/22/2005 | EP1543102A1 Device and method for processing biological material |
| 06/22/2005 | EP1543037A2 Dendritic cell pontentiation |
| 06/22/2005 | EP1543032A2 Method for the rational mutagenesis of a/beta t cell receptors and correspondingly mutated mdm2 protein-specific a/beta t-cell receptors |
| 06/22/2005 | EP1543029A1 Interferon-alpha induced gene |
| 06/22/2005 | EP1543028A2 Live antenuated parasite vaccine |
| 06/22/2005 | EP1543026A1 Transcriptional activator gene for genes involved in cobalamin biosynthesis |
| 06/22/2005 | EP1543025A2 Human g protein-coupled receptor and modulators thereof for the treatment of ischemic heart disease and congestive heart failure |
| 06/22/2005 | EP1543024A2 Cyclic amp phosphodiesterase 4d7 isoforms and methods of use |
| 06/22/2005 | EP1543020A2 Codon optimized synthetic plasmids |
| 06/22/2005 | EP1543018A1 Gene families associated with liver cancer |
| 06/22/2005 | EP1542945A2 Method for the production of zeaxanthin and/or the biosynthetic intermediates and/or subsequent products thereof |
| 06/22/2005 | EP1542731A2 Targeted adenoviral vector displaying immunoglobulin-binding domain and uses thereof |
| 06/22/2005 | EP1542725A2 Method of humanizing immune system molecules |
| 06/22/2005 | EP1542724A2 Antibodies directed to monocyte chemo-attractant protein-1 (mcp-1) and uses thereof |
| 06/22/2005 | EP1542721A1 Modified "s" antibodies |
| 06/22/2005 | EP1542710A1 Methods for preserving organs and tissues |
| 06/22/2005 | EP1542538A2 Lipase inhibitors and uses thereof |
| 06/22/2005 | EP1542536A2 Hematopoietic stem cells and methods of treatment of neovascular eye diseases therewith |
| 06/22/2005 | EP1542532A1 Spliceosome mediated rna trans-splicing for correction of skin disorders |
| 06/22/2005 | EP1542528A1 A method of treatment and prophylaxis |
| 06/22/2005 | EP1542527A2 Transgenic high tryptophan plants |
| 06/22/2005 | EP1501943A4 Method to enhance homologous recombination |
| 06/22/2005 | EP1487565A4 Process for preparing processed sample liquid solution for electrophoresis |
| 06/22/2005 | EP1483408A4 Nanostructures containing pna joining or functional elements |
| 06/22/2005 | EP1472365A4 Receptor capture assay |
| 06/22/2005 | EP1440146A4 Gene targeting methods and vectors |
| 06/22/2005 | EP1417347A4 Vector system for selection of genes encoding secreted proteins and membrane-bound proteins |
| 06/22/2005 | EP1417336A4 Exponential nucleic acid amplification using nicking endonucleases |
| 06/22/2005 | EP1406720A4 Buffers for electrophoresis and use thereof |
| 06/22/2005 | EP1330552A4 Marker assisted selection of bovine for improved milk production using diacylglycerol acyltransferase gene dgat1 |
| 06/22/2005 | EP1261695B1 Methods for making plants tolerant to glyphosate and compositions thereof |
| 06/22/2005 | EP1220944A4 Nuclease inhibitor cocktail |
| 06/22/2005 | EP1204479A4 Multiple fluid sample processor and system |
| 06/22/2005 | EP1196188B1 Vgf selective monoclonal antibodies and their use for treating vgf-related disorders |
| 06/22/2005 | EP1165763B1 Hydantoinase variants with improved properties and their use for the production of amino acids |
| 06/22/2005 | EP1124849B1 Chlamydia 98kd putative outer membrane protein and corresponding dna fragments and uses thereof |
| 06/22/2005 | EP1105360A4 Identification of compound-protein interactions using libraries of protein-nucleic acid fusion molecules |
| 06/22/2005 | EP1100542B1 Peg-urate oxidase conjugates and use thereof |
| 06/22/2005 | EP1017797B1 Non-primate lentiviral vectors and packaging systems |
| 06/22/2005 | EP1007533B1 Bioconjugates and delivery of bioactive agents |
| 06/22/2005 | EP0927254B1 Antagonists of interleukin-15 |
| 06/22/2005 | EP0892644B1 In vivo gene transfer methods for wound healing |